Home Healthcare Medical Devices Neurovascular Devices Market

Neurovascular Devices Market Size, Share & Trends Analysis Report By Product (Embolization Devices, Revascularization Devices Inactivated Vaccines, Thrombectomy Devices, Embolic Protection Devices, Accessory Devices), By Disease Pathology (Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Neurovascular Devices Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Embolization Devices
    2. Revascularization Devices Inactivated Vaccines
    3. Thrombectomy Devices
    4. Embolic Protection Devices
    5. Accessory Devices
  2. Neurovascular Devices Market, By Disease Pathology 2022-2034 (USD MILLION/ Units)
    1. Aneurysm
    2. Arteriovenous Malformation and Fistulas (AVM)
    3. Ischemic Stroke
    4. Stenosis
    5. Others
  3. Regional Neurovascular Devices Market
    1. North America
      1. North America Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      2. North America Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
      3. U.S.
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      4. Canada
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
    2. Europe
      1. Europe Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      2. Europe Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
      3. U.K.
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      4. Germany
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      5. France
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      6. Spain
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      7. Italy
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      8. Russia
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      9. Nordic
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      10. Benelux
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      11. Rest of Europe
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
    3. APAC
      1. APAC Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      2. APAC Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
      3. China
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      4. Korea
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      5. Japan
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      6. India
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      7. Australia
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      8. Taiwan
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      9. South East Asia
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      10. Rest of Asia-Pacific
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
    4. Middle East and Africa
      1. Middle East and Africa Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      2. Middle East and Africa Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
      3. UAE
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      4. Turkey
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      5. Saudi Arabia
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      6. South Africa
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      7. Egypt
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      8. Nigeria
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      9. Rest of MEA
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
    5. LATAM
      1. LATAM Neurovascular Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      2. LATAM Neurovascular Devices Market By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
      3. Brazil
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      4. Mexico
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      5. Argentina
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      6. Chile
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      7. Colombia
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
      8. Rest of LATAM
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
        6. Aneurysm
        7. Arteriovenous Malformation and Fistulas (AVM)
        8. Ischemic Stroke
        9. Stenosis
        10. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.